factual
Direct-to-consumer GLP-1 pricing eliminated list-to-net gap
When pharma sold GLP-1s direct to consumers, the list-to-net gap was eliminated by removing PBMs and insurers, and prices fell from about $1,300 list to about $149 cash, while drugmakers still earned more gross profit.
factualpending
Speaker
Zach ReitanoEvidence Quote
“That list-to-net gap gets entirely eliminated. When people are pointing fingers between insurance companies and PBMs and pharma and who's to blame, they go direct. You remove the PBM and insurance company entirely.”
Source
Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]— Invest Like the BestCreated: 11/17/2026, 7:03:01 AM
Your notes
Loading notes...